Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMN
AMN logo

AMN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy AMN Healthcare Services Inc (AMN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
30.980
1 Day change
-4.32%
52 Week Range
33.130
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

AMN Healthcare Services Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has shown some positive analyst sentiment and bullish moving averages, the recent price decline, lack of significant positive catalysts, and neutral trading sentiment suggest that waiting for clearer growth signals or a more favorable entry point would be prudent.

Technical Analysis

The stock's MACD is negatively expanding (-0.117), indicating bearish momentum. RSI is neutral at 52.185, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 29.671, and resistance is at 32.612. The stock is trading below its pivot point (31.142), reflecting a weak short-term trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • Bullish moving averages and analyst upgrades following strong Q1 results. Analysts have raised price targets, citing better-than-expected labor disruption revenues and improving Nurse and Allied volumes.

Neutral/Negative Catalysts

  • The stock experienced a significant regular market decline of -4.32%. MACD is bearish, and there are no recent news catalysts or significant hedge fund/insider activity. Options data shows a relatively neutral sentiment with a put-call ratio close to 1.

Financial Performance

No financial data available for analysis. However, analysts have noted strong Q1 results with better-than-expected labor disruption revenues and decreasing net debt.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have raised price targets recently, with UBS increasing its target to $32 and maintaining a Neutral rating. Other firms like BMO Capital and Truist have raised targets to $26, citing strong Q1 performance and improving volumes.

Wall Street analysts forecast AMN stock price to fall
5 Analyst Rating
Wall Street analysts forecast AMN stock price to fall
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 32.380
sliders
Low
22
Averages
23.5
High
25
Current: 32.380
sliders
Low
22
Averages
23.5
High
25
UBS
AJ Rice
Neutral
maintain
$32
AI Analysis
2026-05-13
Reason
UBS
AJ Rice
Price Target
$32
AI Analysis
2026-05-13
maintain
Neutral
Reason
UBS analyst AJ Rice raised the firm's price target on AMN Healthcare to $32 from $19.50 and keeps a Neutral rating on the shares. The firm updated its model following the Q1 earnings report.
BMO Capital
Outperform
maintain
$25 -> $26
2026-05-11
Reason
BMO Capital
Price Target
$25 -> $26
2026-05-11
maintain
Outperform
Reason
BMO Capital raised the firm's price target on AMN Healthcare to $26 from $25 and keeps an Outperform rating on the shares. The company's Q1 upside was boosted by better-than-expected labor disruption revenues, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AMN
Unlock Now

People Also Watch